Paul M. Foreman

ORCID: 0000-0001-8743-5119
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Intracranial Aneurysms: Treatment and Complications
  • Cerebrovascular and Carotid Artery Diseases
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Vascular Malformations Diagnosis and Treatment
  • Neurosurgical Procedures and Complications
  • Acute Ischemic Stroke Management
  • Meningioma and schwannoma management
  • Brain Metastases and Treatment
  • Glioma Diagnosis and Treatment
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Cerebrospinal fluid and hydrocephalus
  • Moyamoya disease diagnosis and treatment
  • Management of metastatic bone disease
  • Venous Thromboembolism Diagnosis and Management
  • Vascular Procedures and Complications
  • Spinal Hematomas and Complications
  • Spine and Intervertebral Disc Pathology
  • Aortic aneurysm repair treatments
  • Spinal Fractures and Fixation Techniques
  • Cerebral Venous Sinus Thrombosis
  • Stroke Rehabilitation and Recovery
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Spinal Dysraphism and Malformations
  • CAR-T cell therapy research
  • Virus-based gene therapy research

Orlando Health
2019-2025

TESLA (Czechia)
2024

Neuroscience Institute
2022

Brigham and Women's Hospital
2022

University of Alabama at Birmingham
2013-2021

Harvard University
2017-2020

Geisinger Medical Center
2019-2020

Beth Israel Deaconess Medical Center
2017-2020

Geisinger Health System
2019

University of Toronto
2019

M032 is a second-generation oncolytic herpes simplex virus (oHSV) that selectively replicates in tumor cells. kills cells directly through replication and then proceeds to infect proximity, continuing the process of destruction. In addition this direct activity, carries therapeutic payload—thus acting as gene therapy vector—and causes cell synthesize secrete immunity-stimulating protein interleukin-12 (IL-12) before death.1 Human IL-12 expressed promotes an immune response against surviving...

10.1089/humc.2016.031 article EN Human Gene Therapy Clinical Development 2016-06-01

Thromboembolic complications constitute a significant source of morbidity after neurointerventional procedures. Flow diversion using the pipeline embolization device for treatment intracranial aneurysms necessitates use dual antiplatelet therapy to reduce this risk. The platelet function testing before placement remains controversial.A retrospective review prospectively maintained databases at 3 academic institutions was performed from years 2009 2016 identify patients with treated...

10.1161/strokeaha.116.015308 article EN Stroke 2017-04-15

Abstract Background Radiographic leptomeningeal disease (LMD) develops in up to 30% of patients following postoperative stereotactic radiosurgery (SRS) for brain metastases. However, the clinical relevancy this finding and outcomes after various salvage treatments are not known. Methods Patients with metastases, which 1 was resected treated adjunctive SRS, who subsequently developed LMD were combined from 7 tertiary care centers. pattern categorized as nodular (nLMD) or classical...

10.1093/neuonc/noz049 article EN Neuro-Oncology 2019-02-27

OBJECTIVE Flow diversion for posterior circulation aneurysms performed using the Pipeline embolization device (PED) constitutes an increasingly common off-label use otherwise untreatable aneurysms. The safety and efficacy of this treatment modality has not been assessed in a multicenter study. METHODS A retrospective review prospectively maintained databases at 8 academic institutions was years 2009 to 2016 identify patients with treated PED placement. RESULTS total 129 consecutive underwent...

10.3171/2017.9.jns171376 article EN Journal of neurosurgery 2018-05-04

Postresection hydrocephalus is observed in approximately 30% of pediatric patients with posterior fossa tumors. However, which will develop postresection not known. The Canadian Preoperative Prediction Rule for Hydrocephalus (CPPRH) was developed an attempt to identify this subset patients, allowing the optimization their care. authors sought validate and critically appraise CPPRH.

10.3171/2013.5.peds1371 article EN Journal of Neurosurgery Pediatrics 2013-06-28

Abstract BACKGROUND: To date, the use of flow-diverting Pipeline Embolization Device (PED) for small intracranial aneurysms (≤ 7 mm) has been reported only in single-center series. OBJECTIVE: evaluate safety and efficacy PED a multicenter cohort. METHODS: Five major academic institutions United States provided data on patient demographics, aneurysm features, treatment characteristics consecutive patients with ≤ mm treated between 2009 2015. Radiographic outcome was assessed digital...

10.1227/neu.0000000000001377 article EN cc-by Neurosurgery 2016-08-09

<h3>BACKGROUND AND PURPOSE:</h3> Flow diversion with the Pipeline Embolization Device (PED) for treatment of intracranial aneurysms is associated a high rate aneurysm occlusion. However, clinical and radiographic predictors incomplete occlusion are poorly defined. In this study, at last angiographic follow-up after PED were assessed. <h3>MATERIALS METHODS:</h3> A retrospective analysis consecutive treated between 2009 2016, 3 academic institutions in United States, was performed. Cases...

10.3174/ajnr.a5375 article EN cc-by American Journal of Neuroradiology 2017-09-14
Adam A. Dmytriw Basel Musmar Hamza Salim Assala Aslan Nicole M Cancelliere and 87 more Rachel M. McLellan Oktay Algın Sherief Ghozy Mahmoud Dibas Sovann Lay Adrien Guenego Leonardo Renieri Joseph A. Carnevale Guillaume Saliou Panagiotis Mastorakos Kareem El Naamani Eimad Shotar Kévin Premat Markus Möhlenbruch Michael Kral Omer Doron Charlotte Chung Mohamed M Salem Iván Lylyk Paul M. Foreman Jay A. Vachhani Hamza Shaikh Vedran Župančić Muhammad Ubaid Hafeez Joshua S. Catapano Muhammad Waqas Vincent M. Tutino Mohamed K. Ibrahim Marwa A. Mohammed Çetin İmamoğlu Ahmet Bayrak James D. Rabinov Yifan Ren Clemens M. Schirmer Mariangela Piano Anna Luisa Kühn Caterina Michelozzi Stéphanie Elens Zuha Hasan Robert M. Starke Ameer E Hassan Mark Ogilvie Anh Nguyên Jesse Jones Waleed Brinjikji Marie Teresa Nawka Marios‐Nikos Psychogios Christian Ulfert Jose Danilo Bengzon Diestro Bryan Pukenas Jan Karl Burkhardt Thien Huynh Juan Carlos Martínez-Gutiérrez Muhammed Amir Essibayi Sunil A. Sheth Gary Spiegel Rabih G. Tawk Boris Lubicz Pietro Panni Ajit S Puri Guglielmo Pero Erez Nossek Eytan Raz Monika Killer‐Oberpfalzer Christoph J. Griessenauer Hamed Asadi Adnan H. Siddiqui Allan Brook David Altschul Andrew F. Ducruet Felipe C Albuquerque Robert W. Regenhardt Christopher J. Stapleton Peter Kan Vladimir Kalousek Pedro Lylyk Srikanth Boddu Jared Knopman Mohammad Ali Aziz‐Sultan Stavropoula Tjoumakaris Frédéric Clarençon Nicola Limbucci Hugo Cuellar Pascal Jabbour Vítor Mendes Pereira Aman B. Patel Nimer Adeeb

Background The Woven EndoBridge (WEB) device is frequently used for the treatment of intracranial aneurysms. Postoperative management, including use aspirin, varies among clinicians and institutions, but its impact on outcomes WEB has not been thoroughly investigated. Methods This was a retrospective, multicenter study involving 30 academic institutions in North America, South Europe. Data from 1492 patients treated with were included. Patients categorized into two groups based their...

10.1136/jnis-2023-021082 article EN Journal of NeuroInterventional Surgery 2024-01-18
Adam A. Dmytriw Hamza Salim Basel Musmar Assala Aslan Nicole M Cancelliere and 86 more Rachel M. McLellan Oktay Algın Sherief Ghozy Mahmoud Dibas Sovann Lay Adrien Guenego Leonardo Renieri Joseph A. Carnevale Guillaume Saliou Panagiotis Mastorakos Kareem El Naamani Eimad Shotar Kévin Premat Markus Möhlenbruch Michael Kral Omer Doron Charlotte Chung Mohamed M Salem Iván Lylyk Paul M. Foreman Jay A. Vachhani Hamza Shaikh Vedran Župančić Muhammad Ubaid Hafeez Joshua S. Catapano Muhammad Waqas Vincent M. Tutino Mohamed K. Ibrahim Marwa A. Mohammed Çetin İmamoğlu Ahmet Bayrak James D. Rabinov Yifan Ren Clemens M. Schirmer Mariangela Piano Anna Luisa Kühn Caterina Michelozzi Stéphanie Elens Robert M. Starke Ameer E Hassan Mark Ogilvie Peter B. Sporns Jesse Jones Waleed Brinjikji Marie Teresa Nawka Marios Psychogios Christian Ulfert Jose Danilo Bengzon Diestro Bryan Pukenas Jan‐Karl Burkhardt Thien Huynh Juan Carlos Martínez-Gutiérrez Muhammed Amir Essibayi Sunil A. Sheth Gary Spiegel Rabih G. Tawk Boris Lubicz Pietro Panni Ajit S Puri Guglielmo Pero Erez Nossek Eytan Raz Monika Killer-Oberfalzer Christoph J. Griessenauer Hamed Asadi Adnan H. Siddiqui Allan Brook David Altschul Andrew F. Ducruet Felipe C. Albuquerque Robert W. Regenhardt Christopher J. Stapleton Peter Kan Vladimir Kalousek Pedro Lylyk Srikanth Boddu Jared Knopman Mohammad Ali Aziz‐Sultan Stavropoula Tjoumakaris Frédéric Clarençon Nicola Limbucci Hugo Cuellar Pascal Jabbour Vítor Mendes Pereira Aman B. Patel Nimer Adeeb

10.1007/s10143-024-02341-z article EN Neurosurgical Review 2024-03-14

OBJECTIVE Contemporary treatment for paraophthalmic artery aneurysms includes flow diversion utilizing the Pipeline Embolization Device (PED). Little is known, however, about potential implications of anatomical relationship ophthalmic (OA) origin and aneurysm, especially in smaller aneurysms. METHODS Four major academic institutions United States provided data on small (≤ 7 mm) that were treated with PED between 2009 2015. The OA radiographic outcomes aneurysm occlusion, patency assessed...

10.3171/2015.12.jns152499 article EN Journal of neurosurgery 2016-03-04

OBJECTIVE The Pipeline embolization device (PED) is a routine choice for the endovascular treatment of select intracranial aneurysms. Its success based on high rates aneurysm occlusion, followed by near-zero recanalization probability once occlusion has occurred. Therefore, identification patient factors predictive incomplete last angiographic follow-up critical to its success. METHODS A multicenter retrospective cohort analysis was conducted consecutive patients treated with PED unruptured...

10.3171/2019.1.jns183226 article EN Journal of neurosurgery 2019-04-27

<h3>BACKGROUND AND PURPOSE:</h3> Flow diversion with the Pipeline Embolization Device is increasingly used for endovascular treatment of intracranial aneurysms due to high reported obliteration rates and low associated morbidity. While covered branches in anterior circulation generally asymptomatic, this has not been studied within posterior circulation. The aim study was evaluate association between branch coverage occlusion, as well ischemic events a cohort patients treated Device....

10.3174/ajnr.a5696 article EN cc-by American Journal of Neuroradiology 2018-06-07

Mechanical thrombectomy is the established treatment for acute ischemic stroke due to large vessel occlusion (LVO). The authors sought identify early predictors of a favorable outcome in patients treated with mechanical thrombectomy.

10.3171/2019.10.jns191991 article EN Journal of neurosurgery 2019-12-28
Coming Soon ...